AMSTROGA
DEAD

Serial Number

87648644

Owner

H. Lundbeck A/S

Attorney

Claudia A. Smith

Filing Date

Oct 17, 2017

Add to watchlist:

No watchlists yet
View on USPTO

AMSTROGA Trademark

Serial Number: 87648644

AMSTROGA is a trademark filed by H. Lundbeck A/S on October 17, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

H. Lundbeck A/S (398 trademarks)

Ottiliavej 9
DK-2500 Copenhagen-Valby , DK

Entity Type: 03

Trademark Details

Filing Date

October 17, 2017

Registration Date

Not Registered

Published for Opposition

May 8, 2018

Goods & Services

Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; diagnostic agents, reagents, preparations and substances for medical purposes

Medical apparatus and instruments for use in diagnosing and monitoring vital signs of patients with psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; injection devices for pharmaceuticals, syringes and needles for injections and medical purposes; integrated medical systems, namely, medical diagnostic imaging apparatus and software sold as a unit therewith for managing, measuring, monitoring, assessing, controlling, collecting, storing and examining patient and client data and information captured by the medical system in web-based physical, psychological and neurological examinations conducted at a distance and at a clinic; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 4, 2019 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 4, 2019 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 3, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 8, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 8, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 18, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 2, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 15, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 15, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 15, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 15, 2018 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 23, 2018 GNFN
FINAL REFUSAL E-MAILED
Feb 23, 2018 GNFR
FINAL REFUSAL WRITTEN
Feb 23, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 22, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 22, 2018 CRFA
ASSIGNED TO LIE
Feb 16, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 9, 2018 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jan 19, 2018 GPRN
PRIORITY ACTION E-MAILED
Jan 19, 2018 GPRA
PRIORITY ACTION WRITTEN
Jan 19, 2018 CPRA
ASSIGNED TO EXAMINER
Jan 19, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2017 NWOS
NEW APPLICATION ENTERED
Oct 20, 2017 NWAP